Ease of use of two autoinjectors in patients with multiple sclerosis treated with interferon beta-1a subcutaneously three times weekly: results of the randomized, crossover REDEFINE study.

about

Ease of use of two autoinjectors in patients with multiple sclerosis treated with interferon beta-1a subcutaneously three times weekly: results of the randomized, crossover REDEFINE study.

Item

http://www.wikidata.org/entity/Q47282950

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Ease of use of two autoinjecto ...... zed, crossover REDEFINE study.

@en

Ease of use of two autoinjecto ...... zed, crossover REDEFINE study.

@nl

type

Item

label

Ease of use of two autoinjecto ...... zed, crossover REDEFINE study.

@en

Ease of use of two autoinjecto ...... zed, crossover REDEFINE study.

@nl

prefLabel

Ease of use of two autoinjecto ...... zed, crossover REDEFINE study.

@en

Ease of use of two autoinjecto ...... zed, crossover REDEFINE study.

@nl

P1476

Ease of use of two autoinjecto ...... zed, crossover REDEFINE study.

@en

P2093

Barry Singer

http://www.w3.org/2001/XMLSchema#string

Brooke Hayward

http://www.w3.org/2001/XMLSchema#string

Fernando Dangond

http://www.w3.org/2001/XMLSchema#string

Sibyl Wray

http://www.w3.org/2001/XMLSchema#string

P2860

Single-use autoinjector for peginterferon-β1a treatment of relapsing-remitting multiple sclerosis: safety, tolerability and patient evaluation data from the Phase IIIb ATTAIN study.

An open-label, multicenter study to evaluate the safe and effective use of the single-use autoinjector with an Avonex® prefilled syringe in multiple sclerosis subjects

Patient-rated suitability of a novel electronic device for self-injection of subcutaneous interferon beta-1a in relapsing multiple sclerosis: an international, single-arm, multicentre, Phase IIIb study.

An observational, retrospective, UK and Ireland audit of patient adherence to subcutaneous interferon beta-1a injections using the RebiSmart(®) injection device

A patient care program for adjusting the autoinjector needle depth according to subcutaneous tissue thickness in patients with multiple sclerosis receiving subcutaneous injections of glatiramer acetate.

Patient assessment of an electronic device for subcutaneous self-injection of interferon β-1a for multiple sclerosis: an observational study in the UK and Ireland

Patient Satisfaction with the New Interferon Beta-1b Autoinjector (BETACONNECT™).

Long-term adherence of patients with relapsing-remitting multiple sclerosis to subcutaneous self-injections of interferon β-1a using an electronic device: the RIVER study.

Patient-rated ease of use and functional reliability of an electronic autoinjector for self-injection of subcutaneous interferon beta-1a for relapsing multiple sclerosis.

Results from the single-use autoinjector for self-administration of subcutaneous interferon beta-1a in patients with relapsing multiple sclerosis (MOSAIC) study.

P304

1-9

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/17425247.2018.1407755

http://www.w3.org/2001/XMLSchema#string

P407

English

P577

2017-12-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29206056

http://www.w3.org/2001/XMLSchema#string